How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers

Almenn færsla
dc.contributorHáskóli Íslandsen_US
dc.contributorUniversity of Icelanden_US
dc.contributor.authorChatzidionysiou, Katerina
dc.contributor.authorDelcoigne, Bénédicte
dc.contributor.authorFrisell, Thomas
dc.contributor.authorHetland, Merete L
dc.contributor.authorGlintborg, Bente
dc.contributor.authordreyer, lene
dc.contributor.authorCordtz, René
dc.contributor.authorZobbe, Kristian
dc.contributor.authorNordström, Dan
dc.contributor.authorTrokovic, Nina
dc.contributor.authorAaltonen, Kalle
dc.contributor.authorProvan, Sella Aarrestad
dc.contributor.authorGröndal, Gerður
dc.contributor.authorGudbjornsson, Bjorn
dc.contributor.authorAskling, Johan
dc.contributor.departmentLæknadeild (HÍ)en_US
dc.contributor.departmentFaculty of Medicine (UI)en_US
dc.contributor.schoolHeilbrigðisvísindasvið (HÍ)en_US
dc.contributor.schoolSchool of Health Sciences (UI)en_US
dc.date.accessioned2020-11-13T14:15:39Z
dc.date.available2020-11-13T14:15:39Z
dc.date.issued2020-09-08
dc.descriptionPublisher's version (útgefin grein)en_US
dc.description.abstract[No abstract available]en_US
dc.description.sponsorshipThis study was partly funded by grants from Nord-Forsk and FOREUM.en_US
dc.description.versionPeer Revieweden_US
dc.format.extente001363en_US
dc.identifier.citationChatzidionysiou K, Delcoigne B, Frisell T, et alHow do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registersRMD Open 2020;6:e001363. doi: 10.1136/rmdopen-2020-001363en_US
dc.identifier.doi10.1136/rmdopen-2020-001363
dc.identifier.issn2056-5933
dc.identifier.journalRMD Openen_US
dc.identifier.urihttps://hdl.handle.net/20.500.11815/2202
dc.language.isoenen_US
dc.publisherBMJen_US
dc.relation.ispartofseriesRMD Open;6(2)
dc.relation.urlhttps://syndication.highwire.org/content/doi/10.1136/rmdopen-2020-001363en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectArthritisen_US
dc.subjectBiological Therapyen_US
dc.subjectEpidemiologyen_US
dc.subjectRheumatoiden_US
dc.subjectIktsýkien_US
dc.subjectLíftæknilyfen_US
dc.titleHow do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registersen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dcterms.licenseThis is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.en_US

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Thumbnail Image
Nafn:
e001363.full.pdf
Stærð:
333.89 KB
Snið:
Adobe Portable Document Format
Description:
Publisher´s version
Hlaða niður

Undirflokkur

Greinar- HÍ

Öll gögn í Opnum vísindum eru vernduð af ákvæðum höfundalaga og með öllum réttindum áskildum, nema annað sé tekið fram.